1. Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002;Voordouw;Vaccine,2010
2. European Medicines Agency. Note for guidance on harmonisation of requirements for influenza vaccines (CHMP/BWP/214/96).
3. European Medicines Agency. Guideline on dossier structure and content for pandemic influenza marketing authorisation application (EMEA/CHMP/VEG/4717/2003).
4. European Medicines Agency. Guideline on submission of marketing authorisation applications for pandemic influenza vaccines through the centralised procedure (EMEA/CPMP/4986/03).
5. European Medicines Agency. Guideline on Influenza vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context (CHMP/VWP/263499/06).